:format(webp))
When transporting high-value, time-critical, and temperature-sensitive investigational medicinal products, even unexpected disruptions such as severe weather, geopolitical shifts, and airline delays can jeopardise patient safety and years of clinical research.
QuickSTAT's global operations experts detail our proactive risk-mitigation framework, designed to anticipate challenges before they arise and ensure your critical shipments arrive safely and on time.
Discover how advanced risk assessments and secondary routing strategies are built into every shipment profile to bypass real-time transit bottlenecks.
Understand how local regulatory experts navigate customs requirements to prevent clearance delays during unexpected regulatory shifts.
The implementation of end-to-end monitoring technologies that track location, orientation, and precise temperature variations in real-time.
See how our 24/7 global command centres and specialists take immediate, hands-on action when exceptions occur in transit.
Loading iFrame
Press play to get started.
At the end of every supply chain is a patient waiting for a life-saving therapy; unplanned delays directly impact clinical trial continuity and patient well-being.
Cell and Gene Therapies, personalised medicines, and biologics represent substantial scientific and financial investments that cannot be easily replicated if compromised.
Transforming unpredictable global variables into manageable, structured responses gives pharmaceutical sponsors complete peace of mind throughout the trial lifecycle.
Even a minor delay can risk a temperature excursion; robust planning ensures the integrity of the cold chain remains uncompromised from origin to destination.